85 related articles for article (PubMed ID: 28717744)
1. Influence of HIV/AIDS on Cervical Cancer: A Retrospective Study From Tanzania.
Chambuso RS; Shadrack S; Lidenge SJ; Mwakibete N; Medeiros RM
J Glob Oncol; 2017 Feb; 3(1):72-78. PubMed ID: 28717744
[TBL] [Abstract][Full Text] [Related]
2. Screening and management of precancerous lesions to prevent cervical cancer in low-resource settings.
Sellors J; Lewis K; Kidula N; Muhombe K; Tsu V; Herdman C
Asian Pac J Cancer Prev; 2003; 4(3):277-80. PubMed ID: 14507251
[TBL] [Abstract][Full Text] [Related]
3. DETERMINANT FACTORS OF VISUAL INSPECTION WITH ACETIC ACID (VIA) POSITIVE LESIONS AMONG HIV POSITIVE WOMEN IN MEKELLE HOSPITAL, NORTHERN ETHIOPIA: A CASE CONTROL STUDY.
Gessesse Z; Tadesse Z; Alemayehu M; Hiruye A; Getachew Y; Derbew M; Mariam DH; Mammo D; Eva K; Yebyo H; Michael HG
Ethiop Med J; 2015 Jul; Suppl 2():17-24. PubMed ID: 26591279
[TBL] [Abstract][Full Text] [Related]
4. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and Risk Factors Associated with Precancerous Cervical Cancer Lesions among HIV-Infected Women in Resource-Limited Settings.
Memiah P; Mbuthia W; Kiiru G; Agbor S; Odhiambo F; Ojoo S; Biadgilign S
AIDS Res Treat; 2012; 2012():953743. PubMed ID: 22548156
[TBL] [Abstract][Full Text] [Related]
6. Progression and regression of cervical pap test lesions in an urban AIDS clinic in the combined antiretroviral therapy era: a longitudinal, retrospective study.
Lofgren SM; Tadros T; Herring-Bailey G; Birdsong G; Mosunjac M; Flowers L; Nguyen ML
AIDS Res Hum Retroviruses; 2015 May; 31(5):508-13. PubMed ID: 25693769
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and incidence of syphilis and its association with HIV-1 infection in a population-based study in the Kagera region of Tanzania.
Killewo JZ; Sandström A; Bredberg Råden U; Mhalu FS; Biberfeld G; Wall S
Int J STD AIDS; 1994; 5(6):424-31. PubMed ID: 7849121
[TBL] [Abstract][Full Text] [Related]
8. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus infection in women infected with the human immunodeficiency virus.
Sun XW; Kuhn L; Ellerbrock TV; Chiasson MA; Bush TJ; Wright TC
N Engl J Med; 1997 Nov; 337(19):1343-9. PubMed ID: 9358128
[TBL] [Abstract][Full Text] [Related]
10. Review of screening guidelines for non-AIDS-defining malignancies: evolving issues in the era of highly active antiretroviral therapy.
Tyerman Z; Aboulafia DM
AIDS Rev; 2012; 14(1):3-16. PubMed ID: 22297500
[TBL] [Abstract][Full Text] [Related]
11. The Single-Visit Approach as a Cervical Cancer Prevention Strategy Among Women With HIV in Ethiopia: Successes and Lessons Learned.
Shiferaw N; Salvador-Davila G; Kassahun K; Brooks MI; Weldegebreal T; Tilahun Y; Zerihun H; Nigatu T; Lulu K; Ahmed I; Blumenthal PD; Asnake M
Glob Health Sci Pract; 2016 Mar; 4(1):87-98. PubMed ID: 27016546
[TBL] [Abstract][Full Text] [Related]
12. Squamous intraepithelial lesions of the cervix, invasive cervical carcinoma, and immunosuppression induced by human immunodeficiency virus in Africa. Dyscer-CI Group.
La Ruche G; Ramon R; Mensah-Ado I; Bergeron C; Diomandé M; Sylla-Koko F; Ehouman A; Touré-Coulibaly K; Welffens-Ekra C; Dabis F
Cancer; 1998 Jun; 82(12):2401-8. PubMed ID: 9635533
[TBL] [Abstract][Full Text] [Related]
13. The role of women in the AIDS epidemic.
Sher R
Med Law; 1993; 12(6-8):467-9. PubMed ID: 8183054
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV-negative women in the general population of Tanzania: the PROTECT study.
Dartell M; Rasch V; Kahesa C; Mwaiselage J; Ngoma T; Junge J; Gernow A; Ejlersen SF; Munk C; Iftner T; Kjaer SK
Sex Transm Dis; 2012 Mar; 39(3):201-8. PubMed ID: 22337107
[TBL] [Abstract][Full Text] [Related]
15. Cancer incidence among HIV-positive women in British Columbia, Canada: Heightened risk of virus-related malignancies.
Salters KA; Cescon A; Zhang W; Ogilvie G; Murray MC; Coldman A; Hamm J; Chiu CG; Montaner JS; Wiseman SM; Money D; Pick N; Hogg RS
HIV Med; 2016 Mar; 17(3):188-95. PubMed ID: 26268461
[TBL] [Abstract][Full Text] [Related]
16. Utilisation and outcomes of cervical cancer prevention services among HIV-infected women in Cape Town.
Batra P; Kuhn L; Denny L
S Afr Med J; 2010 Jan; 100(1):39-44. PubMed ID: 20429487
[TBL] [Abstract][Full Text] [Related]
17. Impact of Highly Active Antiretroviral Therapy on the Natural History of Cervical Precancerous Lesions: A 17-Year Institutional Longitudinal Cohort Study.
Patrelli TS; Gizzo S; Peri F; Franchi L; Volpi L; Esposito F; Pedrazzi G; Antoni AD; Modena AB
Reprod Sci; 2014 Jul; 21(7):837-845. PubMed ID: 24336675
[TBL] [Abstract][Full Text] [Related]
18. An Epidemiological Study of Cervical Cancer Trends among Women with Human Immunodeficiency Virus.
Mathis A; Smith UD; Crowther V; Lee T; Suther S
Healthcare (Basel); 2024 Jun; 12(12):. PubMed ID: 38921292
[TBL] [Abstract][Full Text] [Related]
19. Correction: Detection and Associated Factors for Cervical Precancerous Lesions Among HIV-Positive Women from High HIV-Burden Areas - China, 2015-2016.
China CDC Wkly; 2020 Sep; 2(38):751. PubMed ID: 34606523
[TBL] [Abstract][Full Text] [Related]
20. NewsCAP: A decline in precancerous cervical lesions in women ages 18 to 24.
Am J Nurs; 2019 Aug; 119(8):13. PubMed ID: 31356312
[No Abstract] [Full Text] [Related]
[Next] [New Search]
